Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$10.15 USD
-0.20 (-1.93%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $10.15 0.00 (0.00%) 6:50 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Iovance Biotherapeutics, Inc. [IOVA]
Reports for Purchase
Showing records 161 - 180 ( 193 total )
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Data, FDA Visibility, and Another Targeted BLA; Priceless
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Our Thoughts Post CAR-T and the Rise of the Cellicon Valley Summit
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
TILs Continue to Shine at ASCO; Target Increased to $32
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Further Preparations for Commercial Success; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Shocker (Not), LN-145 Granted Breakthrough Therapy Designation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ASCO Melanoma Abstract Data Continue to Solidify Confidence in Pivotal Study
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
1Q19 Results; Upcoming Inflection Points at ASCO; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Important Chess Moves to Head Regulatory Agencies off at the Pass
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Iovance Officially Goes Pivotal; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
TIL Persistence in Patients and Continued Case for Polyclonal Approach; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2018 results; Building the Foundation for TILs in Solid Tumors; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
What We''ve All Been Waiting For, Plus RMAT and a Chunk of Cash; Price Target Raised to $26
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Updated Moffitt Lung Data in Intractable Population Point in Right Direction
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Our Thoughts Post Investor Dinner Event With NSCLC KOL
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q18 Results; Watchful Waiting Ahead of FDA Meeting This Quarter; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Recent News in Space Supportive of Thesis, Not Recent Weakness; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Increased Momentum; Expanding Melanoma Study; Developing Next Gen Manufacturing
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2017 Results; Exciting Times Ahead for TILs
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J